European Regulators Approve Bayer’s Purchase Of GMO & Pesticide Goliath Monsanto

Two years after pharma company Bayer first agreed to purchase GMO and pesticide Goliath Monsanto, European regulators have given their seal of approval to the deal. With an expected price tag of $62.5bn and the combined corporation likely to control more than a quarter of the world’s seed and pesticides market, the approval is conditional on Bayer, formerly a leading member of the infamous IG Farben Cartel, selling parts of its existing business to supposedly ensure the deal doesn’t reduce competition. But in a move seen by some as being just as controversial as the purchase of Monsanto itself, Bayer has proposed chemical company BASF, one of its former IG Farben partners, as buyer for the business assets it will be selling.  

Not surprisingly, the Bayer-Monsanto tie-up has been strongly criticized by health campaigners, farming groups, environmentalists, and the general public alike – all of whom worry it will create a GMO and pesticides monster that will dominate the global food supply. Coming at a time when there is growing worldwide interest in vitamin-rich food produced naturally, locally, and in harmony with the environment, the deal has been widely criticized as “a marriage made in hell.” Despite receiving over a million petitions relating to the takeover, regulators in Europe nevertheless went ahead with their approval – thus indicating they see corporate interests as being more important than the health and lives of European citizens.

The dark history of Bayer and BASF

IG Farben managers and executives in the dock on the first day of the Nuremberg war crimes trial, 17 September, 1947

In July 2007, after they had essentially been gathering dust in international archives for six decades, our Foundation published historic records from the key war crimes trial that determined responsibility for WWII. Comprising tens of thousands of documents from the 1947-1948 Nuremberg Tribunal, the evidence they contain proves that WWII was planned and financed by the IG Farben Cartel. Consisting of Bayer, BASF, Hoechst and other companies, IG Farben was the world’s largest pharmaceutical and chemical conglomerate at that time.

The driving force behind WWII was IG Farben’s ruthless ambition to gain control of the global markets in drugs and chemicals, and then eliminate any competition. Towards achieving this, it had deliberately financed the Nazi party’s rise to power. From a historical perspective, the Nuremberg documents provide a clear warning as to what can happen when corporate and political interests become closely intertwined.

History repeating itself

While over 70 years have passed since the managers and executives of IG Farben were tried at Nuremberg, the basic strategies of both their corporate successors and Monsanto remain strikingly similar. Gaining control of the global markets in drugs, chemicals, and GMOs; eliminating competition; spending millions of dollars on political lobbying and campaigns opposing the passing of democratic GMO labeling legislation: all these things are central to their relentless pursuit of profits.

As Bayer’s purchase of Monsanto still has to be approved in both the U.S. and Russia, we can only hope that regulators there take decisions that better reflect the health interests of citizens. But whatever happens next, one thing is for sure. The longer global regulators and politicians continue to ride roughshod over the interests of citizens, the more likely it is that the voices of those citizens will grow ever louder demanding change. In such circumstances history clearly teaches us that, one way or another, even the largest Goliaths can eventually fall.

• Bio
• Latest Posts

Paul Anthony Taylor

Executive Director of the Dr. Rath Health Foundation and one of the coauthors of our explosive book, “The Nazi Roots of the ‘Brussels EU'”, Paul is also our expert on the Codex Alimentarius Commission and has had eye-witness experience, as an official observer delegate, at its meetings.

Prior to joining the Foundation, Paul's background was in the music industry, where he worked as a keyboard player and programmer with artists including Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas, and Primal Scream.

He first became interested in natural health after falling ill with a chronic fatigue syndrome-related disorder in 1991 and subsequently making a full recovery through the use of natural health therapies. After meeting Dr. Rath and Dr. Niedzwiecki at an anti-Codex rally in Berlin in 2002, Paul was inspired to make a life-changing decision to leave the music industry to work for the Foundation and help defend the right of patients worldwide to have free access to natural health approaches.

You can find Paul on Twitter at @paulanthtaylor

Der Executive Director der Dr. Rath Health Foundation ist einer der Koautoren des explosiven Buchs „Die Nazi-Wurzeln der Brüsseler EU“. Paul ist auch unser Experte zum Thema „Codex Alimentarius-Kommission“ und hat Augenzeugenerfahrung als offizieller beobachtender Teilnehmer bei diesen Treffen.

Bevor er seine Arbeit bei der Stiftung antrat war Paul in der Musikindustrie aktiv. Er arbeitete als Keyboard-Spieler und Programmierer mit Künstlern wie Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas und Primal Scream.

Sein Interesse an natürlicher Gesundheit wuchs, als er 1991 an Störungen erkrankte, die aus einem chronischen Erschöpfungssyndrom resultierten. Durch natürliche Gesundheitstherapien wurde er schließlich vollständig geheilt. Ein Treffen 2002 mit Dr. Rath und Dr. Niedzwiecki bei einer Anti-Codex-Demonstration in Berlin inspirierte ihn zu einer lebensverändernden Entscheidung und er verließ die Musikindustrie um für die Stiftung zu arbeiten und das Recht der Patienten zu verteidigen, weltweit freien Zugang zu natürlichen Gesundheitsverfahren zu haben.

Auf Twitter ist Paul unter @paulanthtaylor zu finden.

Latest posts by Paul Anthony Taylor (see all)

• Plummeting Deaths From Heart Disease in United States Reflect Rise in Use of Dietary Supplements - April 12, 2024
• Growing Evidence of the Protective Effect of Vitamin D Against Breast Cancer - April 5, 2024
• Doctors Report Mysterious Worldwide Cancer ‘Epidemic’ - March 29, 2024
• ‘Definitive’ Evidence Linking Vitamin D to Lower Risk of COVID-19 and ICU Admission - March 22, 2024
• Africa’s Latest Cholera Outbreaks: As Vaccine Stocks Run Out, It’s Time To Consider Alternatives - March 1, 2024